國立高雄大學圖資館 |

Language: English

Back

Helicobacter pylori

Kim, Nayoung.

Helicobacter pylori

Record Type:	Electronic resources : Monograph/item
Title/Author:	Helicobacter pyloriedited by Nayoung Kim.
other author:	Kim, Nayoung.
Published:	Singapore :Springer Singapore :2016.
Description:	x, 556 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Helicobacter pylori infections.
Online resource:	http://dx.doi.org/10.1007/978-981-287-706-2
ISBN:	9789812877062$q(electronic bk.)

Helicobacter pylori
Helicobacter pylori[electronic resource] /edited by Nayoung Kim. - Singapore :Springer Singapore :2016. - x, 556 p. :ill. (some col.), digital ;24 cm.

Part 1. Epidemiology-Prevalence and Transmission routes of H. pylori -- Part 2. Pathophysiology -- 1) Colonization of H. pylori in the stomach -- 2) Brief description of Pathophysiology -- 3) Immune mechanism -- 4) Change of acid secretion, ghrelin and leptin by H. pylori -- 5) H. pylori virulence factors -- A: toxin (CagA, VacA, DupA, OipA, IceA) -- B: genetic polymorphism of toxin and disease -- 6) Host factors: genetic polymorphism, etc -- Part 3. Diagnosis -- 1) Serology -- 2) Histology -- 3) Culture -- 4) UBT -- 5) Stool antigen -- 6) Specific conditions -- A: Children -- B: Bleeding -- Part 4. Symptom -- 1)Symptom of acute and chronic H. pylori infection -- Part 5. Disease -- 1) Atrophic gastritis and Intestinal metaplasia -- 2) Functional dyspepsia -- 3) Peptic ulcer -- 4) MALToma -- 5) Gastric cancer -- A: Synopsis and Epidemiology of gastric cancer -- B1: Pathogenesis: i.Genetic alternation (mutations in tumor-related genes) induced by Activation-induced cytidine deaminase (AID) -- B2: Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA -- B3: Pathogenesis:iii. Macrophage inhibitory factor (MIF) -- B4: Pathogenesis: iv. Epidermal mesenchyme transition (EMT) -- B5: Pathogenesis: v. ABO blood type -- B6: Pathogenesis: vi. First relatives of gastric cancer -- C: H. pylori-negative gastric cancer -- 6) Gastroesophageal reflux disease (GERD) -- 7) NSAID-induced gastropathy and H. pylori infection -- 8) Extraintestinal manifestations of H. pylori infection -- A: Iron deficiency anemia -- B: Idiopathic thrombocytopenic purpura -- C: Heart disease -- D: Atopy and allergy -- Part 6. Antibiotic resistance -- 1) Synopsis of antibiotic resistance -- 2) Clarithromycin -- 3) Amoxicillin -- 4) Quinolone -- 5) Metronidazole -- Part 7. Treatment -- 1) Synopsis of antibiotic treatment -- 2) Triple therapy -- 3) Quadruple therapy -- 4) Sequential therapy -- 5) Concomitant therapy -- 6) Tailored therapy based on antibiotic resistance -- 7) Levofloxacin or rifabutin based triple therapy -- 8) Probiotics -- 9) Treatment guidelines -- 10) Screening method of early gastric cancer -- 11) Recrudescence and reinfection -- Part 8. Consequences of H. pylori eradication -- 1) Peptic ulcer disease -- 2) atrophic gastritis and Intestinal metaplasia -- 3) Gastric cancer -- Part 9. The effect of H. pylori on the other microbiota of stomach -- The effect of H. pylori on the other microbiota of stomach -- Part 10. Animal model- H. pylori, H. felis.

This book presents the current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the global epidemiology of H. pylori infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and treatment methods, guidelines for eradication, antibiotic resistance, the reinfection rate after H. pylori eradication, and animal models of H. pylori or related Helicobacter infection. The aim is to equip readers around the world with the understanding required in order to implement effective methods of H. pylori eradication and to enhance clinical outcomes for patients. The text is clearly written and is complemented by many helpful illustrations. This book will be a great asset in clinical practice for all practitioners who are involved in caring for patients with H. pylori-related diseases or have an interest in the subject. It will also be a useful source of information for medical students and for intelligent laypeople seeking information on H. pylori.

ISBN: 9789812877062$q(electronic bk.)

Standard No.: 10.1007/978-981-287-706-2doiSubjects--Topical Terms:

745198
Helicobacter pylori infections.

LC Class. No.: RC840.H38

Dewey Class. No.: 616.33014

Helicobacter pylori
LDR:04458nmm a2200313 a 4500 001 490813
003 DE-He213
005 20161205171811.0
006 m d
007 cr nn 008maaau
008 170118s2016 si s 0 eng d
020 $a 9789812877062$q(electronic bk.)
020 $a 9789812877055$q(paper)
024 7 $a 10.1007/978-981-287-706-2 $2 doi
035 $a 978-981-287-706-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC840.H38
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.33014 $2 23
090 $a RC840.H38 $b H475 2016
245 0 0 $a Helicobacter pylori $h [electronic resource] / $c edited by Nayoung Kim.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2016.
300 $a x, 556 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part 1. Epidemiology-Prevalence and Transmission routes of H. pylori -- Part 2. Pathophysiology -- 1) Colonization of H. pylori in the stomach -- 2) Brief description of Pathophysiology -- 3) Immune mechanism -- 4) Change of acid secretion, ghrelin and leptin by H. pylori -- 5) H. pylori virulence factors -- A: toxin (CagA, VacA, DupA, OipA, IceA) -- B: genetic polymorphism of toxin and disease -- 6) Host factors: genetic polymorphism, etc -- Part 3. Diagnosis -- 1) Serology -- 2) Histology -- 3) Culture -- 4) UBT -- 5) Stool antigen -- 6) Specific conditions -- A: Children -- B: Bleeding -- Part 4. Symptom -- 1)Symptom of acute and chronic H. pylori infection -- Part 5. Disease -- 1) Atrophic gastritis and Intestinal metaplasia -- 2) Functional dyspepsia -- 3) Peptic ulcer -- 4) MALToma -- 5) Gastric cancer -- A: Synopsis and Epidemiology of gastric cancer -- B1: Pathogenesis: i.Genetic alternation (mutations in tumor-related genes) induced by Activation-induced cytidine deaminase (AID) -- B2: Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA -- B3: Pathogenesis:iii. Macrophage inhibitory factor (MIF) -- B4: Pathogenesis: iv. Epidermal mesenchyme transition (EMT) -- B5: Pathogenesis: v. ABO blood type -- B6: Pathogenesis: vi. First relatives of gastric cancer -- C: H. pylori-negative gastric cancer -- 6) Gastroesophageal reflux disease (GERD) -- 7) NSAID-induced gastropathy and H. pylori infection -- 8) Extraintestinal manifestations of H. pylori infection -- A: Iron deficiency anemia -- B: Idiopathic thrombocytopenic purpura -- C: Heart disease -- D: Atopy and allergy -- Part 6. Antibiotic resistance -- 1) Synopsis of antibiotic resistance -- 2) Clarithromycin -- 3) Amoxicillin -- 4) Quinolone -- 5) Metronidazole -- Part 7. Treatment -- 1) Synopsis of antibiotic treatment -- 2) Triple therapy -- 3) Quadruple therapy -- 4) Sequential therapy -- 5) Concomitant therapy -- 6) Tailored therapy based on antibiotic resistance -- 7) Levofloxacin or rifabutin based triple therapy -- 8) Probiotics -- 9) Treatment guidelines -- 10) Screening method of early gastric cancer -- 11) Recrudescence and reinfection -- Part 8. Consequences of H. pylori eradication -- 1) Peptic ulcer disease -- 2) atrophic gastritis and Intestinal metaplasia -- 3) Gastric cancer -- Part 9. The effect of H. pylori on the other microbiota of stomach -- The effect of H. pylori on the other microbiota of stomach -- Part 10. Animal model- H. pylori, H. felis.
520 $a This book presents the current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the global epidemiology of H. pylori infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and treatment methods, guidelines for eradication, antibiotic resistance, the reinfection rate after H. pylori eradication, and animal models of H. pylori or related Helicobacter infection. The aim is to equip readers around the world with the understanding required in order to implement effective methods of H. pylori eradication and to enhance clinical outcomes for patients. The text is clearly written and is complemented by many helpful illustrations. This book will be a great asset in clinical practice for all practitioners who are involved in caring for patients with H. pylori-related diseases or have an interest in the subject. It will also be a useful source of information for medical students and for intelligent laypeople seeking information on H. pylori.
650 0 $a Helicobacter pylori infections. $3 745198
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Gastroenterology. $3 274091
650 2 4 $a Bacteriology. $3 273947
700 1 $a Kim, Nayoung. $3 750418
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-287-706-2
950 $a Medicine (Springer-11650)